Anticoagulants as Potential SARS-CoV-2 M

Authors :: Ayman, Abo Elmaaty
Wagdy M, Eldehna
Muhammad, Khattab
Omnia, Kutkat
Radwan, Alnajjar
Ahmed N, El-Taweel
Sara T, Al-Rashood
Mohammed A S, Abourehab
Faizah A, Binjubair
Mohamed A, Saleh
Amany, Belal
Ahmed A, Al-Karmalawy
Source :: International journal of molecular sciences. 23(20)
Publication Year :: 2022
Abstract: In this article, 34 anticoagulant drugs were screened in silico against the main protease (M

Subjects :: Ticagrelor
SARS-CoV-2
Heparin
Anticoagulants
Eptifibatide
Molecular Dynamics Simulation
Viral Nonstructural Proteins
Antiviral Agents
Dabigatran
COVID-19 Drug Treatment
Molecular Docking Simulation
Fondaparinux
Humans
Gentian Violet
Protease Inhibitors
Coronavirus 3C Proteases

Tools